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Objective: The aim of this study was to assess the cost effectiveness of silicone and alginate
impressions for complete dentures.
Methods: Cost effectiveness analyses were undertaken alongside a UK single centre, double blind,
controlled, crossover clinical trial. Taking the perspective of the healthcare sector, effectiveness is
measured using the EuroQol (EQ-5D-3L) which provides a single index value for health status that
may be combined with time to produce quality adjusted life years (QALYs); and Oral Health Impact
Profile (OHIP-EDENT). Incremental cost effectiveness ratios are presented representing the addi-
tional cost per one unit gained.
Results: Mean cost was higher in the silicone impression group (£388.57 vs. £363.18). Negligible
between-group differences were observed in QALY gains; the silicone group had greater mean OHIP-
EDENT gains. The additional cost using silicone was £3.41 per change of one point in the OHIP-EDENT.
Conclusions: The silicone group was more costly, driven by the cost of materials. Changes in the EQ-5D
and QALY gains over time and between arms were not statistically significant. Change in OHIP-EDENT
score showed greater improvement in the silicone group and the difference between arms was
statistically significant. Given negligible QALY gains and low level of resource use, results must be
treated with caution. It is difficult to make robust claims about the comparative cost-effectiveness.
Clinical significance: Silicone impressions for complete dentures improve patients’ quality of life
(OHIP-EDENT score). The extra cost of silicone impressions is £30 per patient. Dentists, patients
and health care funders need to consider the clinical and financial value of silicone impressions.
Different patients, different dentists, different health funders will have individual perceptions
and judgements.
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In common with many developed countries the proportion of
adults in England who are edentate has fallen by 22% from 28%
in 1978 to 6% in 2009.1 However tooth loss is age related and
these population wide figures mask the prosthodontic needs
of an elderly population who require dentures; 15% of adults
aged 65–74, 30% aged 75–84 and 47% aged >85 years are
edentulous and require complete dentures.
Experts in prosthodontics concur that the quality of the
dental impression is an important issue for improving the fit
and comfort of a new denture. From the impression materials
available, selection of material is left to the discretion of the
dentist, who makes choices based on personal preference,
experience, impression philosophy and the material used.2 A
survey of impression materials for complete dentures in the
UK3 demonstrated that the majority of dentists used alginate
as the material of choice for the definitive impression material
for complete dentures. This contrasts with the position both
practiced and taught in USA dental schools where experts use
silicon as a favoured alternative to alginate.2,4 Although
impression materials differ in many aspects, there was no
evidence from randomised controlled trials (RCTs) to conclude
that the clinical long-term outcome of dentures fabricated
using varying materials and methods would differ significant-
ly.5 Similarly there is little evidence regarding the cost-
effectiveness of different impression materials, which is
important to assess which material provides the best value
for money. Indeed, only two randomised controlled trials were
found in the field of complete denture impression materials
but neither built cost considerations into their analysis.6,7
A single-centre, randomised controlled cross-over trial was
undertaken to establish the effectiveness and cost-effective-
ness of the use of silicone vs. alginate, and to fill in the
evidence gap for best practice. This paper reports on the cost-
effectiveness analyses.
The aim of this study was to assess the cost effectiveness of
silicone and alginate impressions for complete dentures.
2. Method
The cost effectiveness analysis (CEA) was conducted in
parallel with the crossover RCT in the UK between October
2009 and December 2012. Full details of the RCT protocol and
the clinical outcomes are reported elsewhere.8Within the RCT
each patient received two sets of dentures; made using either
alginate or silicone impressions.
The CEA takes the perspective of the UK NHS health care
system. This includes the cost of resources used to construct
the dentures, costs of adjustments made for both dentures
and other health service costs resulting from problem with the
dentures (for example, GP visits). Within the analyses, the
effectiveness component of the cost effectiveness analysis is
assessed in two ways; using the EQ-5D-3L, a measure of
generic health related quality of life,9 which provides a single
index value for health status that is combined with time to
produce quality adjusted life years (QALYs)10; and the Oral
Health Impact Profile (OHIP-EDENT), a condition specifichealth related quality of life measure adapted for use with
edentulous individuals.11 The second analysis was included
due to concerns that the EQ-5D may not be sensitive enough to
detect changes in this population.
Each patient was followed from baseline to the end of the
second denture adjustment period. Data was collected
prospectively and retrospectively. Prospectively, clinical den-
tal staff recorded the procedures undertaken and the time
taken. This included assessment, undertaking the impres-
sions and any adjustments. Data on patients’ use of other
healthcare as a result of their dental care were collected using
patient self-reported questionnaires administered within the
dental clinic at baseline, 2 weeks assessment and at the end of
each 8 weeks assessment periods. Costs were obtained from
national sources and where necessary adjusted to 2012 prices
using the CCEMG–EPPI Centre Cost Converter.12 Details are
given in Table 1.
Patient responses to the EQ-5D, at baseline, the end of
period 1 and the end of period 2, were converted to health-
state utility values using the UK tariff values13 and an area
under the curve approach. These values were then multiplied
by duration (56 days) of using each denture and divided by 365
to estimate QALYs. QALYs represent a quality-weighted
survival value in which 1 QALY is the equivalent of 1 year
of full health. The OHIP-EDENT questionnaire has 19 items
that are rated on five-point Likert-type scales (range: 0 = never
to 4 = very often). The total score of the scale ranges between
0–76 points, with lower scores indicating better oral health-
related quality of life (OHRQoL). Sum scores were calculated
without item weighting.14
There were no missing values of EQ-5D over time. For the
small number of missing OHIP-EDENT data the missing items
were imputed using the overall medians by treatment over
time. One patient was excluded in our OHIP-EDENT analysis
because the percentage of missing items was greater than
50%. Similarly missing data for costs was minimal; we applied
mean imputation by treatment to deal with these missing
data. Descriptive statistics of costs, EQ-5D and OHIP-EDENT
scores were calculated for each arm of the trial. Crossover
statistical analysis was performed using the pkcross routine in
STATA 12 software (StataCorp LP, College Station, TX) to
evaluate differences in health-related quality-of-life scores
between groups. One-way analyses of variance (ANOVA) and
Fisher’s least significant difference were applied to estimate
overall mean, period effects, treatment effects, and carry-over
effects.
All patients who did not withdraw in the trial were
included. The outcome of the CEA was an incremental cost
per QALY/OHIP-EDENT point. We present incremental cost-
effectiveness ratios (ICERs) representing the ratios of the
incremental cost and incremental benefits (QALYs/OHIP-
EDENT points) between silicone and alginate impressions.
The ICER represents the additional cost per one unit of
outcome gained, in this case per QALY gained (OHIP-EDENT
lost) for silicone vs. alginate. In the UK as a guideline, the
National Institute for Health and Care Excellence (NICE)
accepts as cost-effective those interventions with an ICER of
<£20,000 per QALY. NICE states that, in general, if a treatment
costs >£30,000 per QALY it would not be considered cost-
effective.
Table 1 – Unit costs.
Services Unit cost Source Note
GP, surgery visit (face to face) £43.29 (Curtis, 2012)21 – p183 – with qualification
per minute (£3.70). Including direct care
staff costs
Average visit time is 11.7 min
(PSSRU p. 182) (£3.70  11.7)
GP, surgery visit (tel/email) £26.27 (Curtis, 2012)21 – p183 – with qualification
– lasting 7.1 min
GP, home visit £110.00 (Curtis, 2012)21 – p183 – with qualification
– per visit (Inc. travel time)
Per out of surgery visit lasting
23.4 min
District nurse, home visiting £27.30 (Curtis, 2012)21 – p175/183 – with
qualification – per visit (Inc. travel)
£70 per hour. Assume visit time is
same as GP out of surgery,
i.e. 23.4 min (70/60*23.4)
District nurse, patient-related work £6.86 (Curtis, 2012)21 – p175 – with qualification
– per contact
Assume contact is telephone call
and is same length as GP = 7.1 min
(58/60*7.1)
Hospital inpatient stay £586.00 (Curtis, 2012)21 – p109. Non-elective
inpatient stays (short stays)
Hospital A&E – leading to admitted £152.00 (Lloyd-Jones et al., 2009)22 – dental
care – HRG code: VB10Z
Hospital A&E – not leading to admitted £68.00 (Lloyd-Jones et al., 2009) [22] – dental care
– HRG code: VB10Z
Hospital general outpatient
clinic – dental medicine specialities
£105.00 (Lloyd-Jones et al., 2009)22 – outpatient
attendances – service code: 450
Lab cost: full upper or lower only
with standard teeth (2 for F/F)
£167.05 Mgill website (http://www.mgill.co.uk/
Price_list/index.html), November 2012
Salary Per hour Year 2012 (adjusted for inflation)
(CCEMG – EPPI-centre
cost converter, 2013)
Source
Dentist (NHS, England) £32.87 2011 £33.69 Pay circular (M&D) 1/2011 and PSSRU p. 182
Overheads
% of income Dentist (NHS, England) as above
Wages and NI (per hour) 17.42% £33.69
Overheads (per hour) 12.77% £24.70
Cost of materials Per bag/box Per patient Item
1 £10.99 £0.79 Heraeus/Kulzer Xantalgin select refill bag 500 g (10.99/14)
2 £16.89 £2.41 Impression compound stick Kerr Greenper box (16.89/7)
3 £24.59 £1.64 GC Europe iso functional stick Pink 120 g box (24.59/15)
4 £77.29 £7.73 3 M Espe Express 2 regular body Quick set 4  50 ml (77.29/10)
5 £45.99 £6.57 Kerr Extrude Purple 2  50 ml & tips (45.99/7)
6 £77.29 £19.32 3 M Espe Express 2 light body standard Quick set 4  50 ml (77.29/4)
Total Per patient Notes
Alginate (1,2,3) £4.84 (Green stick and pink stick impressions cost (2.41 + 1.64 + 0.79)
Silicone (3,4,5,6) £35.26 (Heavy medium and light) and pink stick impression cost
(1.64 + 6.57 + 19.32 + 7.73)
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uncertainty in the cost values. We performed the sensitivity
analysis by adding and subtracting 20% of the cost and
assessing the subsequent impact on the ICERs. The value of
20% is essentially arbitrary but it was considered likely to
represent any uncertainty that might exist in parameter
values.
3. Results
85 patients were recruited, of which, 13 patients withdrew
(2 prior to the randomisation, 4 at baseline, 4 at the 2-week
assessment period, 2 at the first 8-week assessment period,
1 at the second 8-week assessment period), and 1 patient died
unrelated to trial procedure. Thus 71 participants are included,34 were randomised to the silicone group and 37 to the alginate
group in period 1; groups received the treatment in the reverse
order in period 2. Cost data at baseline was available for all 71
participants. At the first 8-week assessment period EQ-5D and
OHIP-EDENT were available for all 71 participants (34) silicone,
(37) alginate. At the second 8-week follow-up, EQ-5D were
available for all participants (37) silicone, (34) alginate. OHIP-
EDENT were available for 70 participants (36) silicone, (34)
alginate. The participants had a mean age of 72 (range: 40–89)
and 70.4% were female. The ANOVA showed no period effect
in costs, EQ-5D or OHIP-EDENT (P = 0.24, 0.28 and 0.12,
respectively).
Table 2 shows the mean time spent by the dentist together
with the mean cost for construction and adjustment of the
dentures. The time for primary impression, jaw registration,
try in and fit is common to both the silicone and alginate arms
Table 2 – Procedures and costs.
Resource Silicone Alginate
Time (min) Cost (£) Time (min) Cost (£)
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Baseline
Primary impression 5.74 (2.42) 5.75 (2.33) 5.74 (2.42) 5.75 (2.33)
Secondary impression 17.05 (3.64) 16.59 (3.54) 16.63 (4.29) 16.19 (4.18)
Jaw registration 12.84 (5.13) 12.49 (4.99) 12.84 (5.13) 12.49 (4.99)
Try in 7.52 (5.60) 7.32 (5.45) 7.52 (5.60) 7.32 (5.45)
Fit 8.27 (6.14) 8.05 (5.98) 8.27 (6.14) 8.05 (5.98)
Other 8.58 (6.16) 8.35 (5.99) 8.58 (6.16) 8.35 (5.99)
Adjustment periods
Trimming and polishing 7.88 (5.44) 7.68 (5.30) 7.77 (6.49) 7.56 (6.31)
Rebase/reline (1st appointment) 0.29 (1.74) 0.29 (1.69) 0.00 0.00
Rebase/reline (2nd appointment) 0.01 (0.04) 0.01 (0.04) 0.59 (4.51) 0.58 (4.39)
Chairside adjustment of occlusal errors 0.15 (0.72) 0.14 (0.70) 0.28 (1.29) 0.27 (1.26)
Check record (adjustment of occlusal errors) 0.00 0.00 0.00 0.00
Lab based occlusal adjustment 0.00 0.00 0.00 0.00
Other 0.83 (2.80) 0.81 (2.73) 0.19 (0.45) 0.18 (0.44)
Subtotal 8.97 (5.13) 8.73 (4.99) 8.75 (7.16) 8.52 (6.97)
Material N/A 35.26 N/A 4.84
Total 44.09 13.36
(SD) (4.99) (6.97)
N 71 71
Table 3 – EQ-5D and OHIP-EDENT scores.
EQ-5D
Silicone Alginate
Baseline Mean (SD) 0.73 (0.27) 0.73 (0.27)
N 71 71
Follow-up Mean (SD) 0.71 (0.34) 0.77 (0.26)
Change Mean (SD) 0.02 (0.23) 0.04 (0.20)
OHIP-EDENT
Time point Silicone Alginate
Baseline Mean (SD) 44.20 (17.61) 44.07 (17.52)
N 70a 71
Follow-up Mean (SD) 28.64 (18.92) 36.17 (19.58)
Change Mean (SD) 15.56 (20.51) 7.90 (22.69)
a One patient with missing values of >50% items was excluded.
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difference lies in the time taken for the secondary impression
(the difference between the time taken for the secondary
impression by each arm is not significant (P = 0.897)). There is
no statistically significant difference in the total number of
visits for adjustments between the silicone group and the
alginate group: 62 in the silicone group (61 in the alginate group)
visits for trimming and polishing, 118 visits for the first
appointment of rebase/reline, 78 visits for the second appoint-
ment of rebase/reline, 99 visits for chair side adjustment of
occlusal errors, and 1715 visits for other issues, respectively.
Commercial construction of the dentures was £334.1 which
includes laboratory cost (full upper or lower only with
standard teeth, 2 FF). Table 2 gives details of the procedures
undertaken and associated costs. The extremely short time
reported in the adjustment periods was not for individual
time. This is a range of values for the mean time containing all
the values of zero spent in remedial treatment for all patients
in which the majority of patients required little adjustment or
remedial work.
There was little reported use of healthcare associated with
problems with dentures. Two GP visits were recorded in the
silicone group (one face to face and 1 telephone) and 1
outpatient visit, and 2 GP visits (face to face) and 4 outpatient
visits in the alginate group.
The total mean per patient costs (including the initial cost
of construction) is 388.57 (16.33) for the silicone arm and
£363.18 (44.56) for the alginate arm. The difference in total
costs between two arms is statistically significant at 99% level
(mean difference 25.39, CI: 288.47 to 103.87).
Wilcoxon rank-sum test indicated that changes in EQ-5D
over time were not statistically significant, but changes in
OHIP-EDENT score were at 95% level. In general, the results
indicated small fluctuations in EQ-5D throughout the trial
period, making it difficult to draw conclusions about the
impact of denture materials on generic health-related qualityof life. Table 3 shows the mean difference between baseline
OHIP-EDENT scores and follow-up was around 15 in the
silicone group and 8 in the alginate group.
Differences in QALY gains between groups were minimal.
Within ICER calculations if the intervention costs are higher
and the intervention is less effective than the comparator, the
intervention is said to be dominated by the comparator. In this
case the silicone group was dominated by the alginate group
because the silicone group had the lower QALY gains and the
higher mean total cost over the trial. Table 4 provides the cost-
effectiveness results, showing the incremental costs and
benefits as well as the ICERs for each group. Interpretation
should be tempered given negligible between group differ-
ences observed in QALY gains. In respect of the OHIP-EDENT
the silicone group had the more OHIP-EDENT gains and higher
mean total costs. The ICER shows a cost of £3.41 per change of
one OHIP-EDENT point.
Table 4 – Between-group comparisons of cost-effectiveness.
Treatment Costs (£) QALY Cost/effectiveness
ratio (£/QALY)
Mean SD Between-treatment
increment
Mean SD Between-treatment
increment
Overall
Alginate (N = 71) 363 43 26 0.06 0.02 0.004 5.758 (alginate dominates)
Silicone (N = 71) 389 16 0.05 0.02
Treatment Costs (£) OHIP points Cost/effectiveness
ratio (£/OHIP)
Mean SD Between-treatment
increment
Mean SD Between-treatment
increment
Overall
Alginate (N = 71) 363 43 26 36.17 19.58 7.53 3.41
Silicone (N = 70) 389 18 28.64 18.92
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and effectiveness, we conducted sensitivity analyses and
non-parametric bootstrapping. Univariate sensitivity analy-
sis varied the cost of one material by 20% at a time
while keeping the other constant at base-case value. In
order to assess how a simultaneous change of costs of two
materials affected the ICER, we also varied the costs of both
materials by 20%. Only two scenarios showed silicone to
dominate; where the costs of the alginate were increased by
20%, and where the costs of the silicone were decreased
by 20%.
4. Discussion
Overall, the mean healthcare costs associated with provision
of the dentures and associated healthcare use by the patients
was higher in the silicone impression arm than the alginate
arm (£388.57 vs. £363.18). This difference was almost entirely
driven by the higher cost of the silicone impression materials
(£35.26 vs. £4.84); this was reflected in the sensitivity analyses.
Few patients reported use of other healthcare services as a
result of problems with their dentures and there was little
difference between the number of dental appointments for
adjustment or time required within dental appointments
during the assessment periods. This is in line with previous
studies.7 Wilcoxon rank-sum test indicated that the changes
in EQ-5D over time were not statistically significant but
changes in OHIP-EDENT score were, with silicone showing the
better results. The EQ-5D instrument has been reported to
have adequate construct and convergent validity, but may not
be as sensitive as specific measures of oral health-related
quality of life.15–17 The differences reported here between
general health and oral health shed light on the relatively few
previous studies that relate oral health to health utility and to
cost utility. In general, the results indicated small fluctuations
in EQ-5D throughout the trial period, making it difficult to
draw conclusions about the impact of denture materials on
generic health-related quality of life. Given the apparent
insensitivity of the generic preference based measure (EQ-5D)
future research should explore development of an oral health
related quality of life measure for use in cost-effectiveness
analysis.Dental care professionals may be unfamiliar with the
interpretation of OHIP-EDENT scores, therefore an attempt to
ascertain the magnitude of change that corresponds to a
minimal important difference (MID) would interpret the clinical
relevance of treatment effects. The MID is defined as ‘‘the
smallest difference in scores in the domain of interest which
patients perceive as beneficial and which would mandate, in the
absence of troublesome side effects and excessive cost, a
change in the patient’s management’’.18Allen et al.19 suggest a 9
point difference in OHIP-20 score could be considered the MID
for partially dentate patients. However, for a cross section of
prosthodontic patients, including edentulous patients, John
et al.20 calculated the MID for the full OHIP-49 as 6 OHIP points
(95% confidence interval of 2–9). In this trial, the mean
difference between baseline OHIP-EDENT scores and follow-
up was around 15 in the silicone group and 8 in the alginate
group. Thus, differences in OHIP-EDENT gains between groups
can be seen as beneficial to the patient. Moreover, the analysis
showed an additional cost using silicone per patient of £3.41 per
change of one point in the OHIP-EDENT and a MID is achieved
within the additional cost of using silicone.
The clinical significance of these findings is a balance
between the competing pressures of cost and delivering
improved patient quality of life. Silicone impressions for
complete dentures improve patients’ quality of life (OHIP-
EDENT score). The extra cost of silicone impressions is £30 per
patient. Dentists, patients and health care funders need to
consider the clinical and financial value of silicone impres-
sions. Different patients, different dentists, different health
funders will have individual perceptions and judgements. The
long-term outcome of patients with complete dentures is not
known. Future research in this area is required to clearly
project maintenance costs and effects observed over a longer
time horizon as well as from a broad societal perspective by
combining productivity loss and loss of earnings due to work
absence and out of pocket expenses.
5. Conclusion
The silicone arm was more costly, driven by the cost of
materials. Little change was observed in generic health related
quality of life; however, the change in OHIP-EDENT score
j o u r n a l o f d e n t i s t r y 4 2 ( 2 0 1 4 ) 9 0 2 – 9 0 7 907showed great improvement in the silicone arm and the
difference between arms was statistically significant. Given
the negligible QALY gains and low level of resource use, results
must be treated with caution making it difficult to make robust
claims about the comparative cost-effectiveness of either
material.
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